Literature DB >> 9063545

Multiphasic anaphylaxis: an uncommon event in the emergency department.

W J Brady1, S Luber, C T Carter, A Guertler, G Lindbeck.   

Abstract

OBJECTIVE: To determine the rate of clinically significant recurrence of symptoms in patients treated for anaphylaxis in the ED.
METHODS: Retrospective chart review of out-of-hospital, ED, and hospital records over 4.5-year period (July 1991 to December 1995) at a university hospital ED with an annual patient volume of 60,000. Subjects were ED anaphylaxis patients with > or = 2 of the following 3 organ systems involved: cutaneous, respiratory, and cardiovascular. The major outcome criterion was recurrence of symptoms after ED release. Recurrences were sought at the primary treatment hospital and at surrounding hospitals (radius of 75 miles from the primary institution) within a 7-day period from the initial visit. Review of the state death registry also was made to verify the absence of out-of-hospital deaths.
RESULTS: The medical records of 1,261 allergic reaction patients were reviewed, with 67 (5.3%) cases of anaphylaxis identified. Symptoms and signs in patients during the ED phase included: dyspnea, 42 (63%); pruritus, 38 (57%); emesis, 27 (41%); throat/chest tightness, 25 (37%); orthostatic complaints, 12 (18%); urticaria, 47 (70%); circulatory shock, 32 (48%); upper airway angioedema, 7 (33%); stridor, 11 (16%); and bronchospasm, 20 (30%). Of the 67 patients, 93% had immediate resolution and remained asymptomatic for a mean time of 4.2 hours in the ED. Protracted reaction occurred in 5 cases (3 using beta-adrenergic blocking agents). For 19 (28%) patients admitted to hospital, the mean hospital length of stay was 63 hours. Only 2 (3%) recurrent cases were identified, both manifested solely by urticaria.
CONCLUSION: Recurrent anaphylactic reactions were rare, occurring in 3% of cases and without life threat in this patient population. Selective outpatient management of patients with severe anaphylactic reactions that promptly respond to therapy with complete, rapid resolution may be reasonable. Further study of this medical emergency is required to develop criteria to guide the choice of an outpatient disposition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9063545     DOI: 10.1111/j.1553-2712.1997.tb03739.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  3 in total

1.  Fatal asthma or anaphylaxis?

Authors:  J Rainbow; G J Browne
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

Review 2.  The post-anaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms?

Authors:  Stephen F Kemp
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

3.  Biphasic anaphylaxis to gemifloxacin.

Authors:  Insu Yilmaz; Serkan Doğan; Nuri Tutar; Asiye Kanbay; Hakan Büyükoğlan; Ramazan Demir
Journal:  Asia Pac Allergy       Date:  2012-10-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.